Skip to Content

BMS 1611 (Baraclude 0.5 mg)

Generic Name: entecavir

Pill with imprint BMS 1611 is White, Three-sided and has been identified as Baraclude 0.5 mg. It is supplied by Bristol-Myers Squibb.

Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 1611

Baraclude

Generic Name:
entecavir
Imprint:
BMS 1611
Strength:
0.5 mg
Color:
White
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
polysorbate 80
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
49884-0104 Par Pharmaceutical, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide